SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Dr Lal Pathlabs

BSE: 539524 28 Jun 2025
Healthcare
₹ 2804.35
Dr. Lal Pathlabs Limited specializes in Healthcare Service Provider within the Healthcare sector.

Dr Lal Pathlabs - Share Price & Details

Market Cap
₹24,398
High /Low
3,654 / 2,294
Stock P/E
49.9
Book Value
₹260.0
Dividend Yield
0.82
ROCE
28.9
ROE
₹24.3
Face Value
10.0
PEG Ratio
2.99
EVEBITDA
₹30.0
Debt
157
CMP / FCF
52.1
Debt to equity
₹0.07
NP Ann
492
High price all time
4,246
Piotroski score
₹8.0
Graham Number
584.0
No. Eq. Shares
8.38
Net CF
₹-68.3
Net profit
492
Price to book value
11.2
Interest Coverage
₹29.1
Low price all time
696.0
Industry PE
49.9
Reserves
₹2,089
Free Cash Flow
₹516

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Dr. Lal Pathlabs Limited6024.01484.05772.017.7824,39849.9
ASTRAZENECA PHARMA INDIA LTD.NANANANA22178127.0
Eris Lifesciences Limited4215.2304.74047.72.232215463.0

Peer Comparison Chart


About Dr Lal Pathlabs

Dr. Lal Pathlabs Limited, with Security Code 539524, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Dr. Lal Pathlabs Faces Mixed Technical Signals Amid Market Evaluation Shift

(09 Jun 2025)
Dr. Lal Pathlabs has recently revised its market evaluation, with its stock showing a slight decline. Over the past year, the company has underperformed...
Read more →

Dr Lal PathLabs report in spotlight after leaked test reveals Olympic boxer Imane Khelif has male chromos

(05 Jun 2025)
NEW DELHI: Diagnostic services provider Dr Lal PathLabs is making headlines after a leaked medical report alleged that Olympic gold medalist...
Read more →

Is Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

(26 May 2025)
Dr. Lal PathLabs' (NSE:LALPATHLAB) stock is up by a considerable 18% over the past three months. Given that the market...
Read more →

Dr. Lal Pathlabs Shows Signs Of Rebound After Long Downtrend: SEBI RA Harshit Goel

(18 May 2025)
Dr. Lal Pathlabs Ltd has moved from a long-term downtrend towards a potential uptrend using Wyckoff structure analysis, according to SEBI-registered analyst...
Read more →

Dr. Lal Pathlabs Shows Signs Of Rebound After Long Downtrend: SEBI RA Harshit Goel By Stocktwits

(16 May 2025)
Stocktwits - Dr. Lal Pathlabs Ltd has moved from a long-term downtrend towards a potential uptrend using Wyckoff structure analysis,...
Read more →

Dr Lal Pathlabs Shows Strong Performance Amid Sector Gains and Market Dynamics

(13 May 2025)
Dr Lal Pathlabs experienced significant activity, gaining on May 12, 2025, after two days of decline. The stock outperformed its sector and...
Read more →